ReviewCancers2022

Resistance to TKIs in EGFR-Mutated Non-Small Cell Lung Cancer: From Mechanisms to New Therapeutic Strategies.

Andreas Koulouris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.